Χώρα: Αυστραλία
Γλώσσα: Αγγλικά
Πηγή: Department of Health (Therapeutic Goods Administration)
perindopril erbumine, Quantity: 2 mg
Arrotex Pharmaceuticals Pty Ltd
Perindopril erbumine
Tablet, uncoated
Excipient Ingredients: lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate
Oral
30 tablets
(S4) Prescription Only Medicine
Treatment of hypertension. Treatment of heart failure. In such patients, it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision (the safety and efficacy of perindopril have not been demonstrated for New York Heart Association category IV patients). Patients with established coronary artery disease (see Clinical Trials), who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.
Visual Identification: White to off-white, round convex tablet, embossed with "P2" on one side and ">" (Arrow logo) on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2007-10-03